Skip to main content
News

Statement on the passing of José Baselga

By March 22, 2021No Comments
NewImage

NewImage

BIoHealth Innovation is sad to hear of the passing of Jose Basegla, the Head of the ASTRA Zeneca Oncology R&D business and the Gaithersburg Site Head.
Jose was a strong proponent for making the BIoHealth Capital Region a leading BIoHealth hub with a connected ecosystem. AZ was also a founding member of BIoHealth Innovation and continues to support us today.

An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca. He set our Oncology R&D function on a remarkable trajectory, and his visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that we can all be proud of and that will benefit patients’ lives in the years to come.

 

{iframe}https://www.astrazeneca.com/media-centre/press-releases/2021/statement-on-the-passing-of-jose-baselga.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.